Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Y Look

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|October 29, 1998
A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group studyK Y Look, J A Blessing, C Levenback, et al.
Gynecologic Oncology|January 1, 1995
The fate of the ovaries after radical hysterectomy and ovarian transpositionD D Feeney, D H Moore, K Y Look, et al.
Life Sciences|January 1, 1995
Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetinN Prajda, R L Singhal, Y A Yeh, et al.
Anticancer Research|July 1, 1997
Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinomaK Y Look, D H Moore, G P Sutton, et al.
American Journal of Clinical Oncology|December 1, 1993
A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancerR F Asbury, J A Blessing, K Y Look, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2007
Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyK Y Look, J A Blessing, C M Michener, et al.
American Journal of Obstetrics and Gynecology|June 1, 1993
Blood transfusion and the risk of recurrence in squamous carcinoma of the vulvaK Y Look, M Reisinger, F B Stehman, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Signal transduction and biochemical targeting of ovarian carcinomaG Weber, D F Shen, W Li, et al.
Anticancer Research|November 1, 1996
Increased signal transduction activity and down-regulation in human cancer cellsG Weber, F Shen, N Prajda, et al.
Advances in Enzyme Regulation|January 1, 1995
Regulation of signal transductionG Weber, R L Singhal, N Prajda, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|October 29, 1998
A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group studyK Y Look, J A Blessing, C Levenback, et al.
Gynecologic Oncology|January 1, 1995
The fate of the ovaries after radical hysterectomy and ovarian transpositionD D Feeney, D H Moore, K Y Look, et al.
Life Sciences|January 1, 1995
Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetinN Prajda, R L Singhal, Y A Yeh, et al.
Anticancer Research|July 1, 1997
Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinomaK Y Look, D H Moore, G P Sutton, et al.
American Journal of Clinical Oncology|December 1, 1993
A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancerR F Asbury, J A Blessing, K Y Look, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2007
Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyK Y Look, J A Blessing, C M Michener, et al.
American Journal of Obstetrics and Gynecology|June 1, 1993
Blood transfusion and the risk of recurrence in squamous carcinoma of the vulvaK Y Look, M Reisinger, F B Stehman, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Signal transduction and biochemical targeting of ovarian carcinomaG Weber, D F Shen, W Li, et al.
Anticancer Research|November 1, 1996
Increased signal transduction activity and down-regulation in human cancer cellsG Weber, F Shen, N Prajda, et al.
Advances in Enzyme Regulation|January 1, 1995
Regulation of signal transductionG Weber, R L Singhal, N Prajda, et al.
Pageof 6